Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine reversal of biperiden-induced memory impairment in healthy adults
NL-OMON22111Recruiting
- Sponsor
- Anke Sambeth
- Start
- Dec 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rivastigmine and biperiden (4 arms), sponsored by Anke Sambeth. Primary endpoints: Behavioral memory performance and EEG and event-related potentials during memory tasks. Started Dec 2007; status: recruiting.
02
Drugs
rivastigminebiperiden
Beyond the preview
Go deeper on NL-OMON22111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22111.